Paul Tudor Jones's CLBT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 0 shares of Cellebrite DI Ltd. (CLBT) worth $0, representing 0.00% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in CLBT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 153,623 shares. Largest reduction occurred in Q3 2025, reducing 453,815 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Cellebrite DI (CLBT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cellebrite DI (CLBT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -151,538 | Sold Out | 0 | $0.00 |
| Q1 2026 | +79,457 | Add 110.23% | 151,538 | $13.78 |
| Q4 2025 | +72,081 | New Buy | 72,081 | $18.03 |
| Q3 2025 | -453,815 | Sold Out | 0 | $0.00 |
| Q2 2025 | -88,210 | Reduce 16.27% | 453,815 | $16.00 |
| Q1 2025 | +5,903 | Add 1.10% | 542,025 | $19.43 |
| Q4 2024 | +53,832 | Add 11.16% | 536,122 | $22.03 |
| Q3 2024 | +6,490 | Add 1.36% | 482,290 | $16.84 |
| Q2 2024 | -90,162 | Reduce 15.93% | 475,800 | $11.95 |
| Q1 2024 | +153,623 | Add 37.26% | 565,962 | $11.08 |
| Q4 2023 | +412,339 | New Buy | 412,339 | $8.66 |
Paul Tudor Jones's Cellebrite DI Investment FAQs
Paul Tudor Jones first purchased Cellebrite DI Ltd. (CLBT) in Q4 2023, acquiring 412,339 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Cellebrite DI Ltd. (CLBT) for 11 quarters since Q4 2023.
Paul Tudor Jones's largest addition to Cellebrite DI Ltd. (CLBT) was in Q4 2023, adding 412,339 shares worth $3.57 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 0 shares of Cellebrite DI Ltd. (CLBT), valued at approximately $0.
As of the Q2 2026 filing, Cellebrite DI Ltd. (CLBT) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Cellebrite DI Ltd. (CLBT) was 565,962 shares, as reported at the end of Q1 2024.